ADVANCED IMMUNI T INC has a total of 12 patent applications. Its first patent ever was published in 1993. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are AUSTIN RESEARCH INST, OMNIX MEDICAL LTD and INST SUPERIORE DI SANITA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Israel | 1 | |
#7 | Mexico | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Peptides | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Phipps David James | 3 |
#2 | Doob Penelope Reed | 3 |
#3 | Macfadden Douglas Kevin | 3 |
#4 | Houff Sidney | 3 |
#5 | Adams Merribeth | 3 |
#6 | Carlen Peter Louis | 3 |
#7 | Rathjen Deborah | 3 |
#8 | Aston Roger | 3 |
#9 | Widmer Fred | 3 |
#10 | Farrand Dean | 3 |
Publication | Filing date | Title |
---|---|---|
IL149443D0 | Compositions for treating viral diseases | |
US6265374B1 | Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis | |
US6713445B1 | Peptides for treatment of HIV infection |